Evidence map›Paper›PMID 34571796›Full record

ArticleBiology2021

Clinical Significance of the Head-Up Tilt Test in Improving Prognosis in Patients with Possible Neurally Mediated Syncope.

Kengo Ayabe, Tomoyoshi Komiyama, Misaki Hasegawa, Tetsuri Sakai, Masahiro Morise, Susumu Sakama, Atsuhiko Yagishita, Mari Amino, Yuji Ikari, Koichiro Yoshioka

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kengo AyabeDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Tomoyoshi KomiyamaDepartment of Clinical Pharmacology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.ORCID 0000-0003-2138-0084
Misaki HasegawaDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.ORCID 0000-0003-3893-6333
Tetsuri SakaiDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Masahiro MoriseDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Susumu SakamaDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Atsuhiko YagishitaDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Mari AminoDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Yuji IkariDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.ORCID 0000-0001-5686-4324
Koichiro YoshiokaDepartment of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.
Tokai University · JP

Funding

Japan Society for the Promotion of Science 20K08498Japan Society for the Promotion of Science 21K16037
6 · The paper itself

Abstract

Syncope is commonly encountered in daily clinical practice. Depending on its etiology (benign or life-threatening conditions or environmental triggers), syncope can be neurally mediated (reflex), cardiac, or orthostatic. Furthermore, neurologic disease can cause symptoms that mimic syncope. However, there is limited research on neurally mediated syncope (NMS), which is considered a benign disorder, and close follow-ups are rarely performed. NMS can cause serious clinical events, including severe trauma and car accidents. The head-up tilt test (HUTT) is the gold standard for diagnosing NMS; however, its clinical significance remains unknown, and its relevance to NMS prognosis requires further research. This retrospective study aimed to assess the clinical significance of the HUTT for NMS. We reviewed the charts of 101 patients who underwent HUTT at Tokai University Hospital in Japan between January 2016 and March 2019. During the HUTT, 72 patients (69.2%) experienced syncope. Patients were followed up for 886.1 ± 457.7 days (interquartile range: 518-1293 days). The syncope recurrence rate was 16.9%; however, no significant difference was observed between the two groups (HUTT positive vs. negative) (13.8% vs. 18.1%,

Indexed as

atrial fibrillationatrioventricular blockhypotensionsinoatrial nodetilt-table testvasovagal syncope

Identifiers

PMID34571796
PMCPMC8493797
OpenAlexW3199383601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.